Fighting Polycystic Ovary Syndrome (PCOS) - New Developments in Symptoms Management & Treatment
October 31, 2019
Upcoming / RECENT Talks

Fighting Polycystic Ovary Syndrome (PCOS) - New Developments in Symptoms Management & Treatment

with Dr. Carolyn Alexander
Nov 7, 2019, 6 PM ET
PCOS is a little understood life changing syndrome. What we know about PCOS are the disturbing symptoms it creates in our bodies, but we only know the tip of the iceberg when it comes to reasons behind why these symptoms occur. Moreover, almost 70% of teenage girls/women remain undiagnosed mainly because they dont understand their symptoms and avoid discussing them. We are talking to Dr Carolyn Alexander of Southern California Reproductive Center, about new developments in PCOS symptom management & treatment and PCOS updates from recently held #ASRM2019 Conference. Dr Alexander has conducted extensive research on PCOS and specializes in the treatment of patients facing the diagnosis of PCOS and infertility. Guiding the discussion from the patient panel will be Ashley Levinson @PCOSgurl who has been advocating for PCOS since the last 20 years. Michelle Schwarz, a PCOS patient and researcher, will also be on the panel to discuss about funding and gaps in research in the field of PCOS.
Dr Carolyn Alexander
Ashley Levinson
Dr Michelle Schwarz
Shweta Mishra 
Oct 10, 2019, 11:30 AM ET
Breast cancer is the second most common cancer in women (although men can get it too). Some breast cancers are driven by inherited mutations while most are sporadic, driven by unknown causes or by environmental or behavioral factors like obesity, lack of exercise, or alcohol use. Breast cancer screening aims to reduce the number of women who die from the disease and the statistics tell us that even though the rates of breast cancer now are greater than they were in the early 1980s, fewer women are dying from the disease. However, the scientific evidence backing screening's benefits is mixed. We are talking to Dr. Esserman of UCSF Helen Diller Family Comprehensive Cancer Center about developments in breast cancer screening and new treatments.

Dr Laura J Esserman
April Stearns
Kelsey Smith
Priya Menon 
Sept 30, 2019, 11 AM ET
Multiple myeloma is a heterogenous plasma cell disorder that contains a small fraction of clonogenic stem cells, just like many other cancers. Although the exact nature and biological properties of these cells remain elusive, multiple myeloma stem cells (MMSCs) have pronounced drug resistance and are believed to be the root cause of failure of many myeloma management therapies. We are talking to Dr William Matsui of LIVESTRONG Cancer Institutes to learn about the latest research on multiple myeloma stem cells and their role in novel drug development to treat multiple myeloma. 


Dr William Matsui
Gary Petersen
Jack Aiello 
Cynthia Chmielewski
Shweta Mishra
For any of the talks dial-in to 718-664-6574 to participate and ask a question LIVE On-Air! Only 50 callers permitted at one time so HURRY!
Our Picks

This email was sent to *|EMAIL|*
why did I get this?    unsubscribe from this list    update subscription preferences

TrialX Editor